fda warning letters glp-1 september 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading NCL Issues a Second Alert

Reliable cold-chain delivery

BMJ Open 2021;11(2):e044711

Victims have filed lawsuits in both an MDL in Federal Court and Multicounty litigation in the state of New Jersey alleging that GLP-1 medication caused stomach paralysis

Facility implications of aqueous-based peptide synthesis: By eliminating reliance on corrosive solvents and reducing overall unit operations involved in peptide manufacturing, this approach could significantly reduce the facility burden associated with GLP-1 manufacturing

Physiology, pharmacology and clinical relevance of GLP-1 GLP-1 is a peptide hormone produced within the L cells of the intestine

FXR in liver physiology: Multiple faces to regulate liver metabolism